16,308 results
Search Results
2. Cytotoxicity of ZnO Paper against Cancer Cells.
- Author
-
Su-Yu Liao, Jing-Jenn Lin, Congo Tak-Shing Ching, and You-Lin Wu
- Subjects
CANCER cells ,GAS detectors ,ZINC oxide ,CELL survival ,ANTINEOPLASTIC agents ,CELL lines - Abstract
Paper incorporated with ZnO nanostructures (called ZnO paper) is a flexible substrate material with applications in many areas including UV detectors and gas sensors. In this work, we tested the cytotoxicity of ZnO paper against cancer cells. The ZnO paper was placed in culture media of different cancer cell lines including A549, H1299, and WI38 with and without the targeted anti-lung cancer drugs Iressa and Staurosporine, and cell viability was determined. We found that ZnO nanoparticles were cytotoxic to all the cell lines examined, and cell viability was further reduced by increasing the deposition time of these nanoparticles. In addition, cytotoxicity was enhanced when both the ZnO paper and the anticancer drugs were present in the culture media. Our experimental results indicate that ZnO paper can be used for cytotoxicity test and the development of future novel anticancer drugs. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
3. Replica Plating and in situ Enzymatic Assay of Animal Cell Colonies Established on Filter Paper
- Author
-
Esko, Jeffrey D.
- Published
- 1978
4. Abstracts Frank G. Brooks Award Winning Papers 1980
- Published
- 1980
5. The Genetics Society of America. [Papers Read at the Chicago Meeting]
- Published
- 1934
6. Bryological Papers. II. The Origin of the Cupule of Marchantia
- Author
-
Barnes, Charles R. and Land, W. J. G.
- Published
- 1908
7. Abstracts: Papers Presented at the Eighteenth Annual Meeting of the Tissue Culture Association, June 4-June 7, 1967
- Published
- 1967
8. Abstracts of Papers Presented at the Nineteenth Annual Meeting of the Tissue Culture Association
- Published
- 1968
9. Erechtheum Papers IV. "The Building Called the Erechtheum"
- Author
-
Holland, Leicester B.
- Published
- 1924
- Full Text
- View/download PDF
10. Erechtheum Papers III. The Post-Persian Revision
- Author
-
Holland, Leicester B.
- Published
- 1924
- Full Text
- View/download PDF
11. Contributions to a Knowledge of the Lepidoptera of West Africa. Paper I
- Author
-
Holland, W. J.
- Published
- 1886
- Full Text
- View/download PDF
12. PAPERS FROM THE HARRIMAN ALASKA EXPEDITION. XII. ENTOMOLOGICAL RESULTS (6) : LEPIDOPTERA
- Author
-
Dyar, Harrison G.
- Published
- 1900
13. Abstracts of Papers Presented at the Seventeenth Annual Meeting of the Tissue Culture Association, May 31-June 3, 1966, San Francisco, California
- Published
- 1966
14. Incidences of problematic cell lines are lower in papers that use RRIDs to identify cell lines.
- Author
-
BABIC, ZELJANA, CAPES-DAVIS, AMANDA, MARTONE, MARYANN E., BAIROCH, AMOS, OZYURT, I. BURAK, GILLESPIE, THOMAS H., and BANDROWSKI, ANITA E.
- Subjects
- *
CELL lines , *VIDEO monitors - Abstract
The use of misidentified and contaminated cell lines continues to be a problem in biomedical research. Research Resource Identifiers (RRIDs) should reduce the prevalence of misidentified and contaminated cell lines in the literature by alerting researchers to cell lines that are on the list of problematic cell lines, which is maintained by the International Cell Line Authentication Committee (ICLAC) and the Cellosaurus database. To test this assertion, we text-mined the methods sections of about two million papers in PubMed Central, identifying 305,161 unique cell-line names in 150,459 articles. We estimate that 8.6% of these cell lines were on the list of problematic cell lines, whereas only 3.3% of the cell lines in the 634 papers that included RRIDs were on the problematic list. This suggests that the use of RRIDs is associated with a lower reported use of problematic cell lines. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
15. Antioxidant and Anticancer Roles of a Novel Strain of Bacillus anthracis Isolated from Vermicompost Prepared from Paper Mill Sludge.
- Author
-
Ganguly, Ram Kumar, Midya, Sujoy, and Chakraborty, Susanta Kumar
- Subjects
- *
ANTIOXIDANT analysis , *ACETIC acid , *ADENOCARCINOMA , *ANTINEOPLASTIC agents , *APOPTOSIS , *BACILLUS (Bacteria) , *BIOCHEMISTRY , *BIOLOGICAL assay , *BREAST tumors , *CELL lines , *CELL surface antigens , *CULTURES (Biology) , *DNA , *HETEROCYCLIC compounds , *IMMUNODIAGNOSIS , *INVERTEBRATES , *PHENOMENOLOGY , *MEDICAL research , *PROTEIN kinases , *SEWAGE , *STAINS & staining (Microscopy) , *SUPEROXIDE dismutase , *TRANSFERASES , *WESTERN immunoblotting , *MANUFACTURING industries , *FREE radical scavengers ,TUMOR prevention - Abstract
Mass production of vermicompost using suitable species of earthworms and selecting target organic waste materials has appeared to be a great development in the realm of biotechnological research for the sustainable eco-management. Although, for the bioconversion of organic wastes to vermicompost, suitable earthworm species play major roles, a hoard of bacterial assemblages by virtue of production of different enzymes facilitate the process of vermicomposting. The present study has documented the roles of vermicompost associated bacteria in combating, preventing, and controlling of cancer so as to open a new vista not only in the field of vermitechnology but also on biomedical research. Earthworms’ associated bacterial metabolic products having their unique physicochemical excellence have gained importance due to their roles as a facilitator of apoptosis (programed cell death in a MCF-7 cell line). The antioxidant and anticancer activities of ethyl acetate extracts’ of vermicompost associated bacterium Bacillus anthracis were undertaken by antioxidant assay which revealed maximum DPPH radical scavenging effect (75.79 ± 5.41%) of the extracts’ at 9 00 μg ml-1. Furthermore, the crude extracts obtained from the same bacteria were found to decrease the activity of SOD (superoxide dismutase) with the increase in doses. MTT assay showed potent cytotoxic activity against human breast adenocarcinoma cells (MCF-7) with the IC50 value of 46.64 ± 0.79 μg ml-1. It was further confirmed through Hoechst 33258 staining of nuclear fragmentation assay and DNA fragmentation analysis. Western blotting test has confirmed a downregulation of Akt upon application of crude extracts. Increase of SOD activity along with decrease of Akt level reflects that the mode of action is entirely PI-3K dependent. This study tends to indicate that B. anthracis isolated from vermicompost could be potentially explored for the development of new therapeutic agents, especially against cancer. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
16. Detection of telomerase on upconversion nanoparticle modified cellulose paper.
- Author
-
Wang, Faming, Li, Wen, Wang, Jiasi, Ren, Jinsong, and Qu, Xiaogang
- Subjects
- *
TELOMERASE , *NANOPARTICLE synthesis , *PHOTON upconversion , *FLUORESCENCE , *CELL lines - Abstract
Herein we report a convenient and sensitive method for the detection of telomerase activity based on upconversion nanoparticle (UCNP) modified cellulose paper. Compared with many solution-phase systems, this paper chip is more stable and easily stores the test results. What's more, the low background fluorescence of the UCNPs increases the sensitivity of this method, and the low telomerase levels in different cell lines can clearly be discriminated by the naked eye. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
17. Retraction to: Schizandrin A inhibits proliferation, migration and invasion of thyroid cancer cell line TPC-1 by down regulation of microRNA-429.
- Subjects
THYROID cancer ,CELL lines ,CANCER cells ,PAPER mills ,ELECTRONIC publications - Abstract
IOS Press has retracted the following publication from its online content: [Cancer Biomarkers, 24(4) (2019), 497-508, DOI: 10.3233/CBM-182222] B Schizandrin A inhibits proliferation, migration and invasion of thyroid cancer cell line TPC-1 by down regulation of microRNA-429 b Qiuli Ding, Xiaoyan Li, Yongcun Sun and Xinru Zhang I Department of Ultrasound, Jining No.1 People's Hospital, Jining, Shandong 272000, China i This paper belongs to a set of papers allegedly linked to a paper mill, as described in [[1]]. The editorial office contacted the authors to clarify the allegations, but to date there was no response; therefore the article has been retracted. [Extracted from the article]
- Published
- 2023
- Full Text
- View/download PDF
18. Raman imaging of single living cells: probing effects of non-cytotoxic doses of an anti-cancer drugThis paper was submitted as part of an Analystthemed issue on Optical Diagnosis. The issue includes work which was presented at SPEC 2010 Shedding Light on Disease: Optical Diagnosis for the New Millennium, which was held in Manchester, UK June 26th–July 1st 2010. Other papers on this topic can be found in issue 12 of vol. 135 (2010). This issue can be found from the Analysthomepage (http://www.rsc.org/analyst).
- Author
-
Florence Draux, Cyril Gobinet, Josep Sulé-Suso, Michel Manfait, Pierre Jeannesson, and Ganesh D. Sockalingum
- Subjects
- *
LUNG cancer treatment , *ANTINEOPLASTIC agents , *CANCER chemotherapy , *RAMAN spectroscopy , *CELL lines , *BIOMOLECULES , *NUCLEIC acids - Abstract
Identifying cell response to a chemotherapy drug treatment, in particular at the single cell level, is an important issue in patient management. This study aims at evaluating the effect of gemcitabine on single living cells using micro-Raman imaging. We used as a model the non-small lung cancer cell line, Calu-1, exposed to cytostatic doses (1 nM to 1 μM for 24 h and 48 h) of gemcitabine, an antitumor drug currently used in the treatment of lung cancer. Following drug treatment as a function of doses and incubation times, the Raman maps of single living cells were acquired. Cell biomolecules (DNA, RNA, and proteins) were chemically extracted and their spectral signatures used to evaluate their respective distribution in the cellular spectral information of control and treated cells. The quantification of these distributions reveals a significant effect of 100 nM gemcitabine at 48 h incubation (concomitant decrease of nucleic acids and increase of proteins). PCA analyses performed both on nuclear and extracted biomolecules spectra show a time-dependent effect of the drug. These promising results reveal that effects of subtoxic doses can be monitored at the single cell level highlighting the importance of such studies for clinical applications. [ABSTRACT FROM AUTHOR]
- Published
- 2011
19. The role of cardiolipin and cytochrome c in mitochondrial metabolism of cancer cells determined by Raman imaging: in vitro study on the brain glioblastoma U-87 MG cell line.
- Author
-
Kopeć, Monika, Borek-Dorosz, Aleksandra, Jarczewska, Karolina, Barańska, Małgorzata, and Abramczyk, Halina
- Subjects
CYTOCHROME c ,CELL metabolism ,CANCER cells ,CELL lines ,CARDIOLIPIN ,MITOCHONDRIA - Abstract
In this paper, we present Raman imaging as a non-invasive approach for studying changes in mitochondrial metabolism caused by cardiolipin–cytochrome c interactions. We investigated the effect of mitochondrial dysregulation on cardiolipin (CL) and cytochrome c (Cyt c) interactions for a brain cancer cell line (U-87 MG). Mitochondrial metabolism was monitored by checking the intensities of the Raman bands at 750 cm
−1 , 1126 cm−1 , 1310 cm−1 , 1337 cm−1 , 1444 cm−1 and 1584 cm−1 . The presented results indicate that under pathological conditions, the content and redox status of Cyt c in mitochondria can be used as a Raman marker to characterize changes in cellular metabolism. This work provides evidence that cardiolipin–cytochrome c interactions are crucial for mitochondrial energy homeostasis by controlling the redox status of Cyt c in the electron transport chain, switching from disabling Cyt c reduction and enabling peroxidase activity. This paper provides experimental support for the hypothesis of how cardiolipin–cytochrome c interactions regulate electron transfer in the respiratory chain, apoptosis and mROS production in mitochondria. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
20. Factors influencing the discrimination and classification of prostate cancer cell lines by FTIR microspectroscopyThis paper is part of an Analystthemed issue on Optical Diagnosis. The issue includes work which was presented at SPEC 2008 Shedding Light on Disease: Optical Diagnosis for the New Millennium, which was held in São José dos Campos, São Paulo, Brazil, October 25–29, 2008.
- Author
-
T. J. Harvey, E. Gazi, A. Henderson, R. D. Snook, N. W. Clarke, M. Brown, and P. Gardner
- Subjects
- *
CELL lines , *CELL culture , *CULTURES (Biology) , *CYTOLOGICAL techniques - Abstract
In this study we obtained Fourier transform infrared (FTIR) spectra of fixed prostate cell lines of differing types as well as the primary epithelial cells from benign prostatic hyperplasia (BPH). Results showed that by using multivariate chemometric analysis it was possible to discriminate and classify these cell lines, which gave rise to sensitivity and specificity values of >94% and >98%, respectively. Following on from these results the possible influences of different factors on the discrimination and classification of the prostate cell lines were examined. Firstly, the effect of using different growth media during cell culturing was investigated, with results indicating that this did not influence chemometric discrimination. Secondly, differences in the nucleus-to-cytoplasm (N/C) ratio were examined, and it was concluded that this factor was not the main reason for the discrimination and classification of the prostate cancer (CaP) cell lines. In conclusion, given the fact that neither growth media nor N/C ratio could totally explain the classification it is likely that actual biochemical differences between the cell lines is the major contributing factor. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
21. Raman spectroscopy – a potential platform for the rapid measurement of carbon nanotube-induced cytotoxicityThis paper is part of an Analystthemed issue on Optical Diagnosis. The issue includes work which was presented at SPEC 2008 Shedding Light on Disease: Optical Diagnosis for the New Millennium, which was held in São José dos Campos, São Paulo, Brazil, October 25–29, 2008.
- Author
-
Peter Knief, Colin Clarke, Eva Herzog, Maria Davoren, Fiona M. Lyng, Aidan D. Meade, and Hugh J. Byrne
- Subjects
- *
CELL culture , *CULTURES (Biology) , *CYTOLOGICAL techniques , *CELL lines , *CELL suspensions , *CLONE cells - Abstract
In this study the suitability of Raman spectroscopy for the determination of carbon nanotube mediated toxicity on human alveolar carcinoma epithelial cells (A549) is explored. The exposure of this cell line represents the primary pathway of exposure in humans, that of inhalation. Peak ratio analysis demonstrates a dose-dependent response which correlates to previous toxicological studies. Principal component analysis is employed to further classify cellular response as a function of dose and to examine differences between spectra as a function of exposed concentration. To further illustrate the potential of Raman spectroscopy in this field, Partial Least Squares (PLS) regression and genetic algorithm feature selection have been utilised to demonstrate that clonogenic endpoints, and therefore toxic response, can be potentially predicted from spectra of cells exposed to un-determined doses, removing the need for costly and time consuming biochemical assays. This preliminary study demonstrates the potential of Raman spectroscopy as a probe of cytotoxicity to nanoparticle exposure. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
22. research paper The Bcl-2 family member Bfl-1/A1 is strongly repressed in normal and malignant plasma cells but is a potent anti-apoptotic factor for myeloma cells.
- Author
-
Tarte, Karin, Jourdan, Michel, Veyrune, Jean Luc, Berberich, Ingolf, Fiol, Geneviève, Redal, Nicole, Shaughnessy Jr., John, and Klein, Bernard
- Subjects
- *
PLASMA cells , *B cell differentiation , *APOPTOSIS , *MYELOMA proteins , *CELL lines , *GENE expression - Abstract
Terminal B-cell differentiation is a multi-step process, from short-lived plasmablasts to mature long-lived plasma cells (PC). The anti-apoptotic Bcl-2 family member Bfl-1/A1 plays a critical role in the survival of mature B cells. However, its potential involvement at the later stages of B-cell development remains highly controversial. Our aim was thus to clarify the place of Bfl-1/A1 in the biology of normal PC and in the pathogenesis of multiple myeloma (MM), the major PC dyscrasia. Using gene expression profiling and quantifiable reverse transcription polymerase chain reaction experiments, we found a similar down-regulation of Bfl-1/A1 in both normal immature plasmablasts and mature PC when compared with B cells. In myeloma cells, the level of Bfl-1/A1 was low and Bfl-1/A1 was not a nuclear factor κB-inducible gene. Collectively, these data demonstrate that Bfl-1/A1 is not involved in the prolonged survival of normal mature PC, and that Bfl-1/A1 deregulation is not a common oncogenic event in MM. However, overexpression of Bfl-1/A1 by retroviral transduction promoted autonomous survival of an interleukin-6-dependent myeloma cell line and rendered it less sensitive to dexamethasone. Thus, Bfl-1/A1 transduction could be an interesting tool to obtain myeloma cell lines from primary samples and to favour the in vitro generation of antibody-secreting, long-lived normal PC. [ABSTRACT FROM AUTHOR]
- Published
- 2004
- Full Text
- View/download PDF
23. research paper Troxacitabine and imatinib mesylate combination therapy of chronic myeloid leukaemia: preclinical evaluation.
- Author
-
Orsolic, Nada, Giles, Francis J., Gourdeau, Henriette, Golemovic, Mirna, Beran, Miloslav, Cortes, Jorge, Freireich, Emil J., Kantarjian, Hagop, and Verstovsek, Srdan
- Subjects
- *
MYELOID leukemia , *IMATINIB , *XENOGRAFTS , *DRUG synergism , *LIFE spans , *CELL lines - Abstract
The in vitro and in vivo activity of a deoxycytidine analogue, troxacitabine, alone or in combination with imatinib mesylate (IM), was evaluated against human chronic myeloid leukaemia (CML) cell lines both sensitive (KBM5 and KBM7) and resistant (KBM5-R and KBM7-R) to IM. These cell lines differ in their sensitivity to IM but all showed similar sensitivity to treatment with troxacitabine (IC50 = 0·5–1 μmol/l). Combined treatment with troxacitabine and IM revealed additive or synergistic effects. Greater apoptotic response was seen with combined treatment than with either agent alone in KBM7-R cells. In clonogenic assays, troxacitabine showed activity against mononuclear cells from CML patients (IC50 = 0·01 μmol/l) with either IM-sensitive or resistant disease. In vivo efficacy studies were carried out in severe combined immunodeficient mice bearing KBM5 or KBM5-R cells. Troxacitabine was administered i.p. daily for 5 d starting on day 20, at doses of 5, 10, 20, or 25 mg/kg. IM was administered i.p. twice a day for 10 d at a dose of 50 mg/kg starting on day 25. In this setting of late stage disease, troxacitabine led to a significant increase in life span, while IM did not. When IM was combined with troxacitabine at 10 and 25 mg/kg in the KBM5 xenograft model, a further increase in life span was observed and some mice achieved long-term survival. These data indicate that the combination of troxacitabine and IM has significant preclinical activity in advanced CML and that clinical evaluation of this combination is warranted. [ABSTRACT FROM AUTHOR]
- Published
- 2004
- Full Text
- View/download PDF
24. Antitumor Agents. Part 214:†<fn id="fn1"><no>†</no>For paper 213, see .</fn> Synthesis and Evaluation of Curcumin Analogues as Cytotoxic Agents
- Author
-
Ishida, Junko, Ohtsu, Hironori, Tachibana, Yoko, Nakanishi, Yuka, Bastow, Kenneth F., Nagai, Masahiro, Wang, Hui-Kang, Itokawa, Hideji, and Lee, Kuo-Hsiung
- Subjects
- *
TUMORS , *CELL lines - Abstract
Fifty-eight curcumin analogues were prepared and evaluated for in vitro cytotoxicity against a panel of human tumor cell lines. Compound was the most potent analogue against several cell lines, including HOS (bone cancer) and 1A9 (breast cancer), with ED50 values of 0.97 and <0.63 μg/mL, respectively. [Copyright &y& Elsevier]
- Published
- 2002
- Full Text
- View/download PDF
25. Synthesis, photophysical characterisation, quantum-chemical study and in vitro antiproliferative activity of cyclometalated Ir(III) complexes based on 3,5-dimethyl-1-phenyl-1H-pyrazole and N,N-donor ligands.
- Author
-
Masternak, Joanna, Okła, Karol, Kubas, Adam, Voller, Jiří, Kozlanská, Karolína, Zienkiewicz-Machnik, Małgorzata, Gilewska, Agnieszka, Sitkowski, Jerzy, Kamecka, Anna, Kazimierczuk, Katarzyna, and Barszcz, Barbara
- Subjects
LIGANDS (Biochemistry) ,SCHIFF bases ,NAD (Coenzyme) ,DRUG target ,IN vitro studies ,MOLECULES ,CELL lines - Abstract
In this paper, we present the synthesis of four new complexes: the dimeric precursor [Ir(dmppz)
2 (μ-Cl)]2 (1) (Hdmppz -- 3,5-dimethyl-1-phenyl-1H-pyrazole) and heteroleptic bis-cyclometalated complexes: [Ir(dmppz)2 (Py2 CO)]PF6 •½ CH2 Cl2 (2), [Ir(dmppz)2 (H2 biim)]PF6 •H2 O (3), and [Ir(dmppz)2 (PyBIm)]PF6 (4), with auxiliary N,N-donor ligands: 2-di(pyridyl)ketone (Py2 CO), 2,2'-biimidazole (H2 biim) and 2-(2'-pyridyl)benzimidazole (PyBIm). In the obtained complexes, SC-X-ray analysis revealed that Ir(III) has an octahedral coordination sphere with chromophores of the type {IrN2 C2 Cl2 } (1) or {IrN4 C2 } (2-4). The complexes obtained, which have been fully characterised by physicochemical methods (CHN, TG, FTIR, UV-Vis, PL and ¹H,13 C,15 N NMR), were used to continue our studies on the factors influencing the cytotoxic properties of potential chemotherapeutic agents (in vitro). To this end, the following studies are presented: (i) comparative analysis of the effects on the biological properties of N,N-donor ligands and C,N-donor ligands in the studied complexes, (ii) studies of the interactions of the compounds with the selected molecular target: DNA and BSA (UV-Vis, CD and PL methods), (iii) and the reactivity towards redox molecules: GSH, NADH (UV-Vis and/or ESI-MS methods), (iv) cytotoxic activity (IC50 ) of potential chemotherapeutics against MCF-7, K-562 and CCRF-CEM cell lines. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
26. Paper Withdrawn: Quercetin attenuates high glucose-induced injury in human retinal pigment epithelial cell line ARPE-19 by up-regulation of miR-29b.
- Author
-
Wang, Xuejiao, Li, Hui, Wang, Hao, and Shi, Jingyun
- Subjects
- *
RHODOPSIN , *BIOLOGICAL pigments , *EPITHELIAL cells , *CELL lines , *RETINAL injuries , *QUERCETIN - Published
- 2020
- Full Text
- View/download PDF
27. Folding behaviour of Tachi–Miura polyhedron bellows
- Author
-
Yasuda, Hiromi, Yein, Thu, Tachi, Tomohiro, Miura, Koryo, and Taya, Minoru
- Published
- 2013
28. Glycomapping the fine specificity of monoclonal and polyclonal Lewis antibodies with type-specific Lewis kodecytes and function-spacer-lipid constructs printed on paper.
- Author
-
Williams, Eleanor, Korchagina, Elena, Frame, Tom, Ryzhov, Ivan, Bovin, Nicolai, and Henry, Stephen
- Subjects
ANTIGEN analysis ,IMMUNOHISTOCHEMISTRY ,ENZYME-linked immunosorbent assay ,BLOOD groups ,MONOCLONAL antibodies ,ANIMAL experimentation ,ANTIGEN-antibody reactions ,CELL lines ,IMMUNITY ,MICE ,BLOOD grouping & crossmatching ,BLOOD - Abstract
Background: Lewis serologic reagents frequently give inaccurate phenotyping results. Furthermore these serologic reagents are often used in nonserologic assays such as inhibition and immunohistochemistry. In both scenarios knowledge of the fine specificity and cross-reactivity of these reagents will improve the quality of results obtained.Study Design and Methods: A range of contemporary and historical workshop and developmental Lewis reagents including mouse monoclonal (MoAb) and human and goat polyclonal (PoAb) reagents were evaluated. All were evaluated both against Lewis kodecytes expressing only single Le(a) , Le(b) , ALe(b) , BLe(b) , Le(x) , Le(y) , ALe(y) , or BLe(y) antigens and against the same antigens inkjet printed on a paper-based microplate and analyzed by enzyme immunoassay. Nine clinical samples were also evaluated. A kodecyte antigen dilution sensitivity assay was used to establish the ratio of Le(b) antigen between group A1 /A2 and O RBCs.Results: A continuum of cross-reactivity from Le(x) through to H was observed with MoAbs. All PoAb and few MoAb anti-Le(a) samples and reagents cross-reacted to some degree with Le(b) antigen. Some PoAb and MoAb anti-Le(b) did not cross-react with Le(a) . All polyclonal goat anti-Le(b) reagents showed substantial activity against ALe(b) and BLe(b) , while no MoAb reagent had this activity. A1 RBCs had less than half the Le(b) antigen of A2 /O RBCs.Conclusions: Substantial cross-reactivity of both MoAbs and PoAbs with related antigens highlights the risks of using serologic reagents in nonserologic assays or against synthetic antigens. The lack of ALe(b) activity in anti-Le(b) MoAbs explains their poor performance against blood group A1 Le(a-b+) phenotypes. [ABSTRACT FROM AUTHOR]- Published
- 2016
- Full Text
- View/download PDF
29. Statistical Analysis of Gastric Cancer Cells Response to Broadband Terahertz Radiation with and without Contrast Nanoparticles.
- Author
-
Schreiner, Oliver Daniel, Socotar, Diana, Ciobanu, Romeo Cristian, Schreiner, Thomas Gabriel, and Tamba, Bogdan Ionel
- Subjects
STOMACH tumors ,RADIOTHERAPY ,DATA analysis ,TREATMENT effectiveness ,MAGNETIC resonance imaging ,MANN Whitney U Test ,CELL lines ,STATISTICS ,SPECTRUM analysis ,RADIATION doses ,CONTRAST media ,NANOPARTICLES ,CELLS - Abstract
Simple Summary: The paper describes the statistical analysis of the response of gastric cancer cells and normal cells to broadband terahertz radiation up to 4 THz, both with and without the use of nanostructured contrast agents. A statistical analysis was conducted towards multiple pairwise comparisons in order to identify the narrow THz frequency ranges where the contrast is enhanced and allows a clear identification of tumor cells in the presence of contrast agents. The paper describes the statistical analysis of the response of gastric cancer cells and normal cells to broadband terahertz radiation up to 4 THz, both with and without the use of nanostructured contrast agents. The THz spectroscopy analysis was comparatively performed under the ATR procedure and transmission measurement procedure. The statistical analysis was conducted towards multiple pairwise comparisons, including a support medium (without cells) versus a support medium with nanoparticles, normal cells versus normal cells with nanoparticles, and, respectively, tumor cells versus tumor cells with nanoparticles. When generally comparing the ATR procedure and transmission measurement procedure for a broader frequency domain, the differentiation between normal and tumor cells in the presence of contrast agents is superior when using the ATR procedure. THz contrast enhancement by using contrast agents derived from MRI-related contrast agents leads to only limited benefits and only for narrow THz frequency ranges, a disadvantage for THz medical imaging. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
30. Spontaneous Tumor Regression and Reversion: Insights and Associations with Reduced Dietary Phosphate.
- Author
-
Brown, Ronald B.
- Subjects
CANCER relapse ,FOOD consumption ,AUTOPHAGY ,PROTEIN kinases ,PHOSPHATES ,CELL proliferation ,CELL physiology ,DISEASE remission ,CANCER patients ,PHOSPHATASES ,CELL lines ,ANOREXIA nervosa ,WESTERN diet ,OVERALL survival - Abstract
Simple Summary: In spontaneous tumor regression, tumors shrink and disappear without conventional treatments. This phenomenon challenges the view that cancer is an irreversible genetic disease and that the only treatment option is to kill cancer cells or surgically remove them. In tumor reversion, cancer cells have been shown to return to normal cells when they are transplanted into a normal cellular environment. Additionally, people consuming a Western diet ingest excessive amounts of dietary phosphate, and a dysregulated oversupply of phosphate can be transported into cells, stimulating the cellular growth that forms tumors. Based on reviewed evidence, this paper proposes that reducing excessive dietary phosphate potentially activates tumor regression and reversion, as components of cancer cells are self-digested. Furthermore, fevers and fasting-mimicking diets are associated with tumor regression, which also may be initiated by reduced phosphate intake. Studies are needed to test dietary phosphate reduction in tumor regression and reversion to improve cancer patient survival. Tumors that spontaneously shrink from unknown causes in tumor regression, and that return to normal cells in tumor reversion, are phenomena with the potential to contribute new knowledge and novel therapies for cancer patient survival. Tumorigenesis is associated with dysregulated phosphate metabolism and an increased transport of phosphate into tumor cells, potentially mediated by phosphate overload from excessive dietary phosphate intake, a significant problem in Western societies. This paper proposes that reduced dietary phosphate overload and reregulated phosphate metabolism may reverse an imbalance of kinases and phosphatases in cell signaling and cellular proliferation, thereby activating autophagy in tumor regression and reversion. Dietary phosphate can also be reduced by sickness-associated anorexia, fasting-mimicking diets, and other diets low in phosphate, all of which have been associated with tumor regression. Tumor reversion has also been demonstrated by transplanting cancer cells into a healthy microenvironment, plausibly associated with normal cellular phosphate concentrations. Evidence also suggests that the sequestration and containment of excessive phosphate within encapsulated tumors is protective in cancer patients, preventing the release of potentially lethal amounts of phosphate into the general circulation. Reducing dietary phosphate overload has the potential to provide a novel, safe, and effective reversion therapy for cancer patients, and further research is warranted. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
31. In vitro and in vivo studies of osteoblast cell response to a titanium-6 aluminium-4 vanadium surface modified by neodymium:yttrium-aluminium-garnet laser and silicon carbide paper.
- Author
-
Khosroshahi, M. E., Mahmoodi, M., and Saeedinasab, H.
- Subjects
TITANIUM ,CONNECTIVE tissues ,CARTILAGE cells ,MEDICAL lasers ,LIGAMENTS ,ADSORPTION (Chemistry) ,ANIMAL experimentation ,CARBON compounds ,CELL lines ,CELL physiology ,CHEMISTRY ,INDUSTRIES ,INORGANIC compounds ,LASERS ,MAMMALS ,MATERIALS testing ,MICE ,SCANNING electron microscopy ,SILICON compounds ,SURFACE tension ,OSSEOINTEGRATION ,IN vitro studies ,OSTEOBLASTS ,SURFACE properties ,PHYSIOLOGY - Abstract
The effects of neodymium:yttrium-aluminium-garnet (Nd:YAG) laser and silicon carbide (SiC) paper on the surface micro-topography of titanium-6 aluminium-4 vanadium (Ti6Al4V) alloy were examined in relation to the response of bone cells. The study was performed in three distinct stages: (1) after surface treatment of samples by laser and SiC paper, the surface hardness, surface roughness, corrosion resistance and surface tension were evaluated; (2) the growth of mouse connective tissue fibroblast cells (L-929) on untreated and treated samples was assessed in vitro; (3) the response of goat osteoblast cells to untreated and treated implanted samples was assessed in vivo. The surface roughness varied between 7 +/- 0.02 for laser-treated samples (LTSs) at 140 J cm(-2) and 21.8 +/- 0.05 for mechanically treated samples (MTSs). The surface hardness was found to vary from 377 Vickers hardness number (VHN) for MTSs to 850 VHN for LTSs. A corrosion potential of -0.21V was achieved for the LTSs compared with -0.51V for the MTSs. The LTSs exhibited a more hydrophilic behaviour (i.e. wettability) than did the MTSs. No cytotoxicity effect, unlike for the MTSs, was observed for the LTSs. The results of in vivo tests indicated longitudinal growth of osteoblast cells along the grooves on the samples formed by the SiC paper, and multidirectional spreading of the cells on the LTSs. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
32. Cells Expressing the DG42 Gene from Early Xenopus embryos Synthesize Hyaluronan
- Author
-
Meyer, Michael F. and Kreil, Günther
- Published
- 1996
33. Grading Multiple Choice Exams with Low-Cost and Portable Computer-Vision Techniques
- Author
-
Fisteus, Jesus Arias, Pardo, Abelardo, and García, Norberto Fernández
- Published
- 2013
- Full Text
- View/download PDF
34. T-Cell Engagers—The Structure and Functional Principle and Application in Hematological Malignancies.
- Author
-
Cech, Paweł, Skórka, Katarzyna, Dziki, Laura, and Giannopoulos, Krzysztof
- Subjects
ONCOLYTIC virotherapy ,HEMATOLOGIC malignancies ,T cells ,LYMPHOCYTIC leukemia ,ANTINEOPLASTIC agents ,IMMUNOTHERAPY ,IMMUNOGLOBULINS ,PROTEIN-tyrosine kinase inhibitors ,HEMATOLOGY ,MONOCLONAL antibodies ,CELL lines ,CANCER chemotherapy ,IMMUNE checkpoint inhibitors ,MOLECULAR structure - Abstract
Simple Summary: Recent advancements in cancer research have proven immunotherapies to be a promising strategy for the treatment of hematological malignancies. The bispecific antibody (BsAb) format was developed to overcome the issues of monoclonal antibody-based therapies. T-cell engagers (TCEs) are BsAbs, which directly activate T-cells and their anti-tumor features, ultimately resulting in the lysis of the targeted tumor cells. In 2014, the FDA approved blinatumomab for treatment of acute lymphoblastic leukemia. As of November 2023, seven clinically approved TCE therapies are on the market. In this paper, we summarized the technical basis of the TCE technology, its application in hematology, and its current issues and prospects. Recent advancements in cancer immunotherapy have made directing the cellular immune response onto cancer cells a promising strategy for the treatment of hematological malignancies. The introduction of monoclonal antibody-based (mAbs) targeted therapy has significantly improved the prognosis for hematological patients. Facing the issues of mAb-based therapies, a novel bispecific antibody (BsAb) format was developed. T-cell engagers (TCEs) are BsAbs, which simultaneously target tumor-associated antigens on tumor cells and CD3 molecules present on T-cells. This mechanism allows for the direct activation of T-cells and their anti-tumor features, ultimately resulting in the lysis of tumor cells. In 2014, the FDA approved blinatumomab, a TCE directed to CD3 and CD19 for treatment of acute lymphoblastic leukemia. Since then, numerous TCEs have been developed, allowing for treating different hematological malignancies such as acute myeloid leukemia, multiple myeloma, and non-Hodgkin lymphoma and Hodgkin lymphoma. As of November 2023, seven clinically approved TCE therapies are on the market. TCE-based therapies still have their limitations; however, improving the properties of TCEs, as well as combining TCE-based therapies with other forms of treatment, give hope to find the cures for currently terminal diseases. In this paper, we summarized the technical basis of the TCE technology, its application in hematology, and its current issues and prospects. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
35. PermuteDDS: a permutable feature fusion network for drug-drug synergy prediction.
- Author
-
Zhao, Xinwei, Xu, Junqing, Shui, Youyuan, Xu, Mengdie, Hu, Jie, Liu, Xiaoyan, Che, Kai, Wang, Junjie, and Liu, Yun
- Subjects
DRUG synergism ,COMBINATION drug therapy ,CELL lines ,HIGH throughput screening (Drug development) ,DRUG interactions ,DRUG delivery devices - Abstract
Motivation: Drug combination therapies have shown promise in clinical cancer treatments. However, it is hard to experimentally identify all drug combinations for synergistic interaction even with high-throughput screening due to the vast space of potential combinations. Although a number of computational methods for drug synergy prediction have proven successful in narrowing down this space, fusing drug pairs and cell line features effectively still lacks study, hindering current algorithms from understanding the complex interaction between drugs and cell lines. Results: In this paper, we proposed a Permutable feature fusion network for Drug-Drug Synergy prediction, named PermuteDDS. PermuteDDS takes multiple representations of drugs and cell lines as input and employs a permutable fusion mechanism to combine drug and cell line features. In experiments, PermuteDDS exhibits state-of-the-art performance on two benchmark data sets. Additionally, the results on independent test set grouped by different tissues reveal that PermuteDDS has good generalization performance. We believed that PermuteDDS is an effective and valuable tool for identifying synergistic drug combinations. It is publicly available at https://github.com/littlewei-lazy/PermuteDDS. Scientific contribution: First, this paper proposes a permutable feature fusion network for predicting drug synergy termed PermuteDDS, which extract diverse information from multiple drug representations and cell line representations. Second, the permutable fusion mechanism combine the drug and cell line features by integrating information of different channels, enabling the utilization of complex relationships between drugs and cell lines. Third, comparative and ablation experiments provide evidence of the efficacy of PermuteDDS in predicting drug-drug synergy. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
36. Striking similarities between publications from China describing single gene knockdown experiments in human cancer cell lines.
- Author
-
Byrne, Jennifer and Labbé, Cyril
- Abstract
Comparing 5 publications from China that described knockdowns of the human TPD52L2 gene in human cancer cell lines identified unexpected similarities between these publications, flaws in experimental design, and mis-matches between some described experiments and the reported results. Following communications with journal editors, two of these TPD52L2 publications have been retracted. One retraction notice stated that while the authors claimed that the data were original, the experiments had been out-sourced to a biotechnology company. Using search engine queries, automatic text-analysis, different similarity measures, and further visual inspection, we identified 48 examples of highly similar papers describing single gene knockdowns in 1-2 human cancer cell lines that were all published by investigators from China. The incorrect use of a particular TPD52L2 shRNA sequence as a negative or non-targeting control was identified in 30/48 (63%) of these publications, using a combination of Google Scholar searches and visual inspection. Overall, these results suggest that some publications describing the effects of single gene knockdowns in human cancer cell lines may include the results of experiments that were not performed by the authors. This has serious implications for the validity of such results, and for their application in future research. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
37. EXTRACTION AND CHARACTERIZATION OF LIPOPOLYSACCHARIDE FROM SERRATIA RUBIDAEA AND ITS CYTOTOXICITY ON LUNG CANCER CELL LINE-NCI-H69.
- Author
-
Renukadevi, K. P., Angayarkanni, J., and Karunakaran, G.
- Subjects
LIPOPOLYSACCHARIDES ,CELL-mediated cytotoxicity ,LUNG cancer ,CELL lines ,PAPER chromatography - Abstract
The present study was carried out on Lipopolysaccride from Serratia rubidaea followed by its partial purification, characterization, evaluation of its Cytotoxicity on Lung Cancer Cell Line. LPS was extracted from Serratia rubidaea and detected by the addition of Schiff's reagent. The various subgroups such as 2-KDO, uronic acid and 4-amino arabinose were detected by paper chromatography and the subgroups such as Lipid A and free amino groups were detected by Thin layer chromatography. Partial purification of the extracted LPS was done by SDS-PAGE in which bands were obtained in ladder like patterns. The presence of fatty acids, esters, phosphates in LPS of S.rubidaea were revealed by GC-MS analysis. LPS was found to exhibit cytotoxicity on the lung cancer cell line NCI-H69. [ABSTRACT FROM AUTHOR]
- Published
- 2012
38. Misspellings or "miscellings"—Non‐verifiable and unknown cell lines in cancer research publications.
- Author
-
Oste, Danielle J., Pathmendra, Pranujan, Richardson, Reese A. K., Johnson, Gracen, Ao, Yida, Arya, Maya D., Enochs, Naomi R., Hussein, Muhammed, Kang, Jinghan, Lee, Aaron, Danon, Jonathan J., Cabanac, Guillaume, Labbé, Cyril, Davis, Amanda Capes, Stoeger, Thomas, and Byrne, Jennifer A.
- Subjects
MICROSATELLITE repeats ,RESEARCH integrity ,NUCLEOTIDE sequence ,CELL lines ,ONLINE library catalogs - Abstract
Reproducible laboratory research relies on correctly identified reagents. We have previously described gene research papers with wrongly identified nucleotide sequence(s), including papers studying miR‐145. Manually verifying reagent identities in 36 recent miR‐145 papers found that 56% and 17% of papers described misidentified nucleotide sequences and cell lines, respectively. We also found 5 cell line identifiers in miR‐145 papers with misidentified nucleotide sequences and cell lines, and 18 cell line identifiers published elsewhere, that did not represent indexed human cell lines. These 23 identifiers were described as non‐verifiable (NV), as their identities were unclear. Studying 420 papers that mentioned 8 NV identifier(s) found 235 papers (56%) that referred to 7 identifiers (BGC‐803, BSG‐803, BSG‐823, GSE‐1, HGC‐7901, HGC‐803, and MGC‐823) as independent cell lines. We could not find any publications describing how these cell lines were established. Six cell lines were sourced from cell line repositories with externally accessible online catalogs, but these cell lines were not indexed as claimed. Some papers also stated that short tandem repeat (STR) profiles had been generated for three cell lines, yet no STR profiles could be identified. In summary, as NV cell lines represent new challenges to research integrity and reproducibility, further investigations are required to clarify their status and identities. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
39. The Phenotypical Characterization of Dual-Nature Hybrid Cells in Uveal Melanoma.
- Author
-
Marcotte, Emily, Goyeneche, Alicia, Abdouh, Mohamed, Burnier, Julia Valdemarin, and Burnier Jr., Miguel Noel
- Subjects
UVEA cancer ,MELANOMA ,IMMUNOCHEMISTRY ,MACROPHAGES ,DATA analysis ,CELL proliferation ,APOPTOSIS ,FISHER exact test ,CHI-squared test ,DESCRIPTIVE statistics ,METASTASIS ,CELL culture ,CELL lines ,GENE expression ,STATISTICS ,MICROSCOPY ,DATA analysis software ,PHENOTYPES ,REGRESSION analysis - Abstract
Simple Summary: Uveal melanoma (UM) is a rare type of cancer of the eye that develops from a cell type called melanocytes, which are present in the uveal tract. These patients have a high risk of liver metastasis, usually many years after the initial diagnosis, which is life threatening. We discovered a population of cells in the primary tumor called dual-nature hybrid cells (DNCs) similar to previously discovered cells in the blood (i.e., circulating hybrid cells, CHCs) with shared characteristics of both cancer cells and white blood cells. In this paper, we determined the types of white blood cells capable of participating in the formation of a hybrid cell with a cancer cell, and we re-created these DNCs in a cell culture. The study of the cells of this tumor, particularly DNCs, is crucial to better understanding dissemination and uncovering a possible target for treatment of this systemic disease. Background: Metastasis, occurring years after primary diagnosis, represents a poor prognosis in uveal melanoma (UM)-affected individuals. The nature of cells involved in this process is under debate. Circulating hybrid cells that have combined tumor and immune cell features found in blood were predictive of metastasis and may correspond to dual-nature cells (DNC) in the primary tumor. Herein, we sought to determine the presence of DNCs in primary UM tumors, the cell types involved in their genesis, and their ability to be formed in vitro. Methods: UM lesions (n = 38) were immunolabeled with HMB45 in combination with immune-cell-specific antibodies. In parallel, we co-cultured UM cells and peripheral blood mononuclear cells (PBMCs) to analyze DNC formation. Results: HMB45
+ /CD45+ DNCs were present in 90% (26/29) of the tumors, HMB45+ /CD8+ DNCs were present in 93% (26/28), and HMB45+ /CD68+ DNCs were present in 71% (17/24). DNCs formed with CD8+ and CD68+ cells were positively correlated to the infiltration of their respective immune cells. Notably, UM cells were prone to hybridize with PBMCs in vitro. Conclusions: This phenotypical characterization of DNCs in UM demonstrates that CD8+ T-cells and macrophages are capable of DNC formation, and they are important for better understanding metastatic dissemination, thus paving the path towards novel therapeutic avenues. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
40. Inorganic Nanomedicine—Mediated Ferroptosis: A Synergistic Approach to Combined Cancer Therapies and Immunotherapy.
- Author
-
Mohapatra, Adityanarayan, Mohanty, Ayeskanta, and Park, In-Kyu
- Subjects
TUMOR treatment ,OXIDATION-reduction reaction ,IMMUNOTHERAPY ,ANTINEOPLASTIC agents ,NANOMEDICINE ,INORGANIC compounds ,LIPID peroxidation (Biology) ,CELL lines ,CELL death ,METABOLISM ,NANOPARTICLES - Abstract
Simple Summary: Ferroptosis is a regulated form of cell death driven by iron and lipid peroxidation, showing great potential in cancer therapy, particularly for tumors that resist conventional treatments. In our review, we focus on the role of inorganic nanoparticles in inducing ferroptosis and how this can be combined with therapies such as chemotherapy, radiotherapy, immunotherapy, and phototherapy. These nanoparticles not only trigger ferroptosis to kill cancer cells but also enhance the body's immune system response against tumors. The review discusses significant progress in using nanomedicine to promote ferroptosis and highlights its potential to improve treatment outcomes. Additionally, we explore the metabolic processes involved, particularly how interactions between iron, lipid, and redox pathways regulate ferroptosis in tumor cells. Understanding these mechanisms is crucial for developing more effective cancer treatments. As research in this field advances, the opportunity to move ferroptosis-based therapies from the lab to clinical practice increases. This combination of ferroptosis with inorganic nanomedicine offers a promising strategy for creating more targeted and powerful cancer therapies, ultimately improving patient survival and expanding treatment possibilities. Ferroptosis, a form of regulated cell death characterized by iron-dependent lipid peroxidation, has generated substantial interest in cancer therapy. Various methods have been developed to induce ferroptosis in tumor cells, including approved drugs, experimental compounds, and nanomedicine formulations. Unlike apoptosis, ferroptosis presents unique molecular and cellular features, representing a promising approach for cancers resistant to conventional treatments. Recent research indicates a strong link between ferroptosis and the tumor immune microenvironment, suggesting the potential of ferroptosis to trigger robust antitumor immune responses. Multiple cellular metabolic pathways control ferroptosis, including iron, lipid, and redox metabolism. Thus, understanding the interaction between tumor metabolism and ferroptosis is crucial for developing effective anticancer therapies. This review provides an in-depth discussion on combining inorganic nanoparticles with cancer therapies such as phototherapy, chemotherapy, radiotherapy, and immunotherapy, and the role of ferroptosis in these combination treatments. Furthermore, this paper explores the future of tumor treatment using nanomedicine, focusing on how inorganic nanoparticles can enhance ferroptosis in tumor cells and boost antitumor immunity. The goal is to advance ferroptosis-based nanomedicine from the laboratory to clinical applications. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
41. Antimigratory Effect of Lipophilic Cations Derived from Gallic and Gentisic Acid and Synergistic Effect with 5-Fluorouracil on Metastatic Colorectal Cancer Cells: A New Synthesis Route.
- Author
-
Suárez-Rozas, Cristian, Jara, José Antonio, Cortés, Gonzalo, Rojas, Diego, Araya-Valdés, Gabriel, Molina-Berrios, Alfredo, González-Herrera, Fabiola, Fuentes-Retamal, Sebastián, Aránguiz-Urroz, Pablo, Campodónico, Paola Rossana, Maya, Juan Diego, Vivar, Raúl, and Catalán, Mabel
- Subjects
CELL migration inhibition ,IN vitro studies ,CELL migration ,VASCULAR endothelial growth factors ,MITOCHONDRIA ,RESEARCH funding ,APOPTOSIS ,COLORECTAL cancer ,CELLULAR signal transduction ,AMP-activated protein kinases ,REVERSE transcriptase polymerase chain reaction ,DESCRIPTIVE statistics ,METASTASIS ,CELL lines ,PLANT extracts ,CELL culture ,CYTOTOXINS ,PHENOLS ,MOLECULAR structure ,ORGANOPHOSPHORUS compounds ,MICROBIOLOGICAL assay ,WESTERN immunoblotting ,MATRIX metalloproteinases ,ONE-way analysis of variance ,FLUOROURACIL ,CELL survival ,DATA analysis software ,DISEASE progression - Abstract
Simple Summary: Colorectal cancer (CRC) is one of the most common causes of death worldwide. Today, this disease does not have an effective treatment, leading to the exploration of novel pharmacological molecules. In this paper, we design and synthesize with a new synthetic route the lipophilic cation derived from gallic acid (TPP
+ C10 ) and gentisic acid (GA-TPP+ C10 ), both able to reach mitochondria and uncouple the electron transport chain. Our results show that combining 5-fluorouracil with GA-TPP+ C10 has a synergistic cytotoxic effect on CRC cells. Both compounds show antimigratory effects, decreasing signaling pathways and biomarkers. Our results show that mitochondrial agents could be an alternative to standard CRC drugs against this disease. Colorectal cancer (CRC) is the third leading cause of cancer deaths in the world. Standard drugs currently used for the treatment of advanced CRC—such as 5-fluorouracil (5FU)—remain unsatisfactory in their results due to their high toxicity, high resistance, and adverse effects. In recent years, mitochondria have become an attractive target for cancer therapy due to higher transmembrane mitochondrial potential. We synthesized gallic acid derivatives linked to a ten-carbon aliphatic chain associated with triphenylphosphonium (TPP+ C10 ), a lipophilic cationic molecule that induces the uncoupling of the electron transport chain (ETC). Other derivatives, such as gentisic acid (GA-TPP+ C10 ), have the same effects on colorectal cancer cells. Although part of our group had previously reported preparing these structures by a convergent synthesis route, including their application via flow chemistry, there was no precedent for a new methodology for preparing these compounds. In this scenario, this study aims to develop a new linear synthesis strategy involving an essential step of Steglich esterification under mild conditions (open flask) and a high degree of reproducibility. Moreover, the study seeks to associate GA-TPP+ C10 with 5FU to evaluate synergistic antineoplastic effects. In addition, we assess the antimigratory effect of GA-TPP+ C10 and TPP+ C10 using human and mouse metastatic CRC cell lines. The results show a new and efficient synthesis route of these compounds, having synergistic effects in combination with 5FU, increasing apoptosis and enhancing cytotoxic properties. Additionally, the results show a robust antimigratory effect of GATPP+ C10 and TPP+ C10 , reducing the activation pathways linked to tumor progression and reducing the expression of VEGF and MMP-2 and MMP-9, common biomarkers of advanced CRC. Moreover, TPP+ C10 and GA-TPP+ C10 increase the activity of metabolic signaling pathways through AMPK activation. The data allow us to conclude that these compounds can be used for in vivo evaluations and are a promising alternative associated with conventional therapies for advanced colorectal cancer. Additionally, the reported intermediates of the new synthesis route could give rise to analog compounds with improved therapeutic activity. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
42. Immunpatológiai folyamatok célzott gyógyszeres gátlásának mechanizmusai.
- Author
-
EDIT, VERECKEI
- Subjects
ARTIFICIAL intelligence ,CELLULAR signal transduction ,CELL lines ,GROWTH factors ,CYTOKINES ,INFLAMMATION ,RHEUMATOLOGY ,RHEUMATISM ,IMMUNOMODULATORS - Abstract
Copyright of Lege Artis Medicine (LAM) is the property of LifeTime Media Kft. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2024
- Full Text
- View/download PDF
43. Lipid Composition, Cytotoxic and Acetylcholinesterase Inhibition Effects of Two Brown Algae Species Lobophora tsengii and Lobophora australis.
- Author
-
Thi Minh Nguyet Hoang, Thi Kim Dung Dao, Thi Thu Thuy Tran, Thi Thu Huong Trinh, Lan Nhi Nguyen, Duc Tien Dam, Guerrae, Idania Rodeiro, and Lan Phuong Doan
- Subjects
BROWN algae ,CYTOTOXINS ,FATTY acids ,PHOSPHOLIPIDS ,CELL lines - Abstract
In this paper, the lipid classes, compositions of the neutral lipids, phospholipids and fatty acids, acetylcholinesterase inhibition and cytotoxic activity of two brown algae Lobophora tsengii D. Tien & Z. Sun and Lobophora australis Z. Sun, F. C. Gurgel & H. Kawai have been investigated. The polar lipid class had the highest content in total lipid (TL) (43.47% in L. tsengii and 48.95% in L. australis). Phosphatidylcholine (PC) and phosphatidylethanolamine (PE) were the main components in the phospholipids of two studied brown algae with contents varied from 32.27% to 52.33%. Total lipids were rich in PUFA (42.54% of total fatty acids for L. australis and 32.98% for L. tsengii), with EPA (11.46%, 14.30%) and AA (8.0%, 11.96%). L. tsengii methanol extract inhibited acetylcholinesterase (AChE) in in vitro assay with an IC
50 value of 25.45 µg/mL. Both Lobophora methanol extracts display cytotoxic effects against four human cancer cell lines (KB, MCF7, HepG2 and A549) with IC50 in the range of 21.11-83.61 µg/mL. Especially, L. australis extract showed a strong cytotoxicity against KB cell lines with IC50 value of 21.11±0.39 µg/mL. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
44. Network-driven cancer cell avatars for combination discovery and biomarker identification for DNA damage response inhibitors.
- Author
-
Papp, Orsolya, Jordán, Viktória, Hetey, Szabolcs, Balázs, Róbert, Kaszás, Valér, Bartha, Árpád, Ordasi, Nóra N., Kamp, Sebestyén, Farkas, Bálint, Mettetal, Jerome, Dry, Jonathan R., Young, Duncan, Sidders, Ben, Bulusu, Krishna C., and Veres, Daniel V.
- Subjects
DNA repair ,BIOCOMPLEXITY ,CANCER cells ,CELL lines ,AVATARS (Virtual reality) - Abstract
Combination therapy is well established as a key intervention strategy for cancer treatment, with the potential to overcome monotherapy resistance and deliver a more durable efficacy. However, given the scale of unexplored potential target space and the resulting combinatorial explosion, identifying efficacious drug combinations is a critical unmet need that is still evolving. In this paper, we demonstrate a network biology-driven, simulation-based solution, the Simulated Cell™. Integration of omics data with a curated signaling network enables the accurate and interpretable prediction of 66,348 combination-cell line pairs obtained from a large-scale combinatorial drug sensitivity screen of 684 combinations across 97 cancer cell lines (BAC = 0.62, AUC = 0.7). We highlight drug combination pairs that interact with DNA Damage Response pathways and are predicted to be synergistic, and deep network insight to identify biomarkers driving combination synergy. We demonstrate that the cancer cell 'avatars' capture the biological complexity of their in vitro counterparts, enabling the identification of pathway-level mechanisms of combination benefit to guide clinical translatability. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
45. Molecular Hybrid Design, Synthesis, In Vitro Cytotoxicity, In Silico ADME and Molecular Docking Studies of New Benzoate Ester-Linked Arylsulfonyl Hydrazones.
- Author
-
Ergan, Erdem, Çakmak, Reşit, Başaran, Eyüp, Mali, Suraj N., Akkoc, Senem, and Annadurai, Sivakumar
- Subjects
CELL lines ,MOLECULAR docking ,CYTOTOXINS ,CHEMICAL synthesis ,ANTINEOPLASTIC agents ,HYDRAZONE derivatives - Abstract
In this paper, we present the synthesis and characterization of two known sulfonyl hydrazides (1 and 2) and their new sulfonyl hydrazone derivatives (9–20), as well as in vitro and in silico investigations of their cytotoxic properties against human lung (A549) and human breast (MCF-7) cancer cell lines. The target compounds (9–20) obtained in high yields were synthesized for the first time by a multi-step reaction, and their structures were confirmed by elemental analysis and various spectral techniques, including FT-IR,
1 H-, and13 C-NMR. The antiproliferative profiles of these compounds (1, 2, and 9–20) in this study were determined at concentrations of 200, 100, 50, and 25 µM against selected cancer cell lines for 72 h using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) method. Except for compounds 1 and 2, other compounds (9–20) demonstrated cytotoxic activity at concentrations lower than 200 µM. The newly synthesized compounds (9–20) demonstrated antiproliferative activities at a micromolar level, with IC50 values in the range of 29.59–176.70 μM for the A549 cell line and 27.70–170.30 μM for the MCF-7 cell line. Among these compounds, compound 15 (IC50 = 29.59 μM against A549 cell line and IC50 = 27.70 μM against MCF-7 cell line) showed the highest cytotoxic activity against these two cancer cell lines compared to the reference drug cisplatin (IC50 = 22.42 μM against A549 cell line and IC50 = 18.01 μM against MCF-7 cell line). From docking simulations, to establish a plausible binding mode of compounds, we noticed that compound 15 demonstrated the highest affinity (−6.8508 kcal/mol) for estrogen receptor-beta (ERbeta) compared to others, suggesting promising ERbeta binding potential. Most compounds followed Lipinski's rule of five, with acceptable logP values. Additionally, all had mixed gastrointestinal absorption and limited blood–brain barrier permeability. Overall, our study proposed new sulfonyl hydrazones as a potential class of anticancer agents. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
46. A decade of GigaScience: What can be learned from half a million RRIDs in the scientific literature?
- Author
-
Bandrowski, Anita
- Subjects
SCIENTIFIC literature ,SOFTWARE development tools ,CELL lines - Abstract
Research resource identifiers (RRIDs) are persistent unique identifiers for scientific resources used to conduct studies such as reagents and tools. Inclusion of these identifiers into the scientific literature has been demonstrated to improve the reproducibility of papers because resources, like antibodies, are easier to find, making methods easier to reproduce. RRIDs also dramatically reduce the use of problematic resources, such as contaminated cell lines. The addition of RRIDs into a manuscript means that authors have to look up information that they may have previously omitted or confront information about problems that may have been reported about their resources. The use of RRIDs is primarily driven by champion journals, such as GigaScience and others. Although still nascent, this practice lays important groundwork for citation types that can cover non-traditional scholarly output, such as software tools and key reagents; giving authors of various types of tools scholarly credit for their contributions. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
47. Correction to PV1 downregulation via shRNA inhibits the growth of pancreatic adenocarcinoma xenografts.
- Subjects
XENOGRAFTS ,DOWNREGULATION ,ADENOCARCINOMA ,CELL lines - Abstract
A correction has been made to an article titled "Correction to PV1 downregulation via shRNA inhibits the growth of pancreatic adenocarcinoma xenografts." The correction involves an error in the assembly of panel 4A in Figure 4, which has been corrected. Additionally, there is a removal of data obtained with the BxPC-3 cell line from the article due to uncertainty about its publication in another paper. However, this removal does not affect the conclusions of the paper. The corrections also include changes to the abstract, methods, results, and discussion sections of the article. [Extracted from the article]
- Published
- 2023
- Full Text
- View/download PDF
48. Anti-proliferative activity and phytochemical study of the methanolic extract from the pods of Gleditsia caspica Desf.
- Author
-
MIRZAEIDARBAND, Samira, SAMADISHAMS, Sara, HAMEDEYAZDAN, Sanaz, ESKANDARI, Zahra, EBRAHIMI, Atefeh, BAMDAD—MOGHADDAM, Sedigheh, BARAR, Jaleh, OMIDI, Yadollah, KHODAIE, Laleh, and NAZEMIYEH, Hossein
- Subjects
PHYTOCHEMICALS ,SAPONINS ,ALKALOIDS ,CELL lines ,EXTRACTS ,CELL proliferation ,CELL survival ,QUERCETIN - Abstract
Gleditsia caspica Desf. (Caesalpinaceae) is traditionally used to treat diverse diseases. This research paper aims to investigate anti-proliferative properties and phytochemical compounds of methanolic extract from the pods of G. caspica. MTT test was used to measure in vitro anti-proliferative effect of the soxhlet-extracted methanolic extract of G.caspica pods with the concentration ranging from 25-1000 μg/ml against A549 cell line. The extract was applied to SPE, HPLC preparative system, and spectral analysis (1HNMR, 13CNMR, and UV) for fractionation, purification, and identification of phytoconstituents, respectively. The results indicated that the extract prevented proliferation of A549 cell line dependent on time and concentration. After 48 h and 72 h, there was a significant decrease in cell viability initiated from 100 and 500 (μg/ml) concentrations in comparison to untreated control. Phytochemical assessment of the extract resulted in two alkaloids, locustoside A and saikachinoside A, and four flavonoids quercetin-3,7-diglucoside, luteolin-4',7–diglucoside, quercetin-3-glucoside, and quercetin. This experiment was an activity-guided phytochemical study. In prior studies, quercetin and quercetin-3-β-D-glucoside showed in vitro inhibitory effect on proliferation of A549 cell line. However, the cytotoxic properties of the other identified compounds have not been reported. Cytotoxic properties of G.caspica was previously attributed to saponins, while isolated flavonoids and alkaloids could be responsible for the extract’s cytotoxic effects. This paper first explored cytotoxic activity of methanolic extract from the pods of G.caspica on A549 cell line and identified flavonoids and alkaloids of this plant. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
49. Jacalin-Curcumin Complex Sensitizes the Breast Cancer MDA-MB-231 Cell Line.
- Author
-
Petrova, Lidiya, Gergov, Nikolay, Stoup, Marie, Zapryanova, Silvina, Van Damme, Els J. M., Lebègue, Nicolas, Liberelle, Maxime, Zasheva, Diana, and Bogoeva, Vanya
- Subjects
CANCER cells ,TRIPLE-negative breast cancer ,BREAST cancer ,CELL lines ,CELL physiology ,BREAST - Abstract
Protein–drug interactions are crucial for understanding drug delivery and cell functions. Jacalin is a suitable molecule for such targeting, as it specifically recognizes the tumor-associated Thomsen–Friedenreich (TF) antigen that is expressed on the glycosylated proteins in cancer cells. The present paper describes the interaction of curcumin and jacalin, a possible carrier molecule for the delivery of antitumor drugs due to its ability to recognize tumor cells. Our results have shown that both steady-state fluorescence and fluorescent labelling of jacalin are two reliable methods to determine jacalin-curcumin interactions. The affinity of jacalin for curcumin is consistently within the micromolar range (using fluorescence and microscale thermophoresis) showing high-affinity binding of the complex. In vitro experiments on triple-negative breast cancer MDA-MB-231 cells indicated inhibition of cell growth after treating with the jacalin-curcumin complex for 48 h. The cell survival fraction was significantly reduced to 50% after combined treatment. In this paper, we report for the first time about the jacalin-curcumin interaction. We quantified this unique biomolecular interaction and gathered additional information on the binding event. We observed that the jacalin-curcumin complex inhibits the proliferation of the triple-negative breast cancer MDA-MB-231 cells. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
50. THE LINE IS FINE
- Author
-
Diebes, Joe
- Published
- 2011
- Full Text
- View/download PDF
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.